Moving a molecule from a laboratory assay to a patient requires a flawless roadmap. We architect robust translational strategies, design optimized pre-clinical proof-of-concept models, and structure data to align perfectly with regulatory expectations and pharmaceutical partner requirements.

Focus: Architecting robust translational roadmaps, optimizing pre-clinical proof-of-concept models, and aligning data with regulatory and pharmaceutical partner expectations.

Tier 1: IND-Readiness & Proof-of-Concept Gap Analysis

What they get: An intensive data structure audit. We evaluate your current laboratory assays against regulatory expectations and identify structural flaws or gaps in your pre-clinical proof-of-concept model before you transition to IND-enabling studies.

Pricing: $200/h (Custom pricing upon consultation).

Tier 2: Comprehensive Translational Roadmap Architecture (Milestone Fee)

What they get: A complete, end-to-end bench-to-market strategic blueprint. We design optimized pre-clinical testing protocols, structure historical assay data to match international regulatory frameworks, and build the data asset packages required to attract big pharma partnerships.

Pricing: Depending on the complexity across project milestones.

Tier 3: Full-Scale Asset Commercialization & Partnership Execution (Bespoke)

What they get: Deep hands-on advisory through active out-licensing campaigns or international regulatory filings. Includes custom data framing for major pharmaceutical partner negotiations, live regulatory presentation defense strategies, and ongoing protocol adjustment.

Pricing: Bespoke Pricing Structure (Tailored on scope; typically structures a premium base fee combined with a milestone success framework, Pricing available upon consultation).